BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/6/2020 9:07:37 AM | Browse: 1114 | Download: 2794
Publication Name World Journal of Clinical Cases
Manuscript ID 55921
Country China
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Respiratory System
Manuscript Type Retrospective Study
Article Title Efficacy and safety of S-1 maintenance therapy in advanced non-small-cell lung cancer patients
Manuscript Source Unsolicited Manuscript
All Author List Xiao-Wei Cheng, Wen-Hua Leng and Chun-Ling Mu
ORCID
Author(s) ORCID Number
Xiao-Wei Cheng http://orcid.org/0000-0001-5607-4023
Wen-Hua Leng http://orcid.org/0000-0003-1205-9221
Chun-Ling Mu http://orcid.org/0000-0002-3572-5103
Funding Agency and Grant Number
Corresponding Author Chun-Ling Mu, BM BCh, Attending Doctor, Department of Ultrasound, Panzhihua Central Hospital, No. 34 Yikang Street, East District, Panzhihua 617067, Sichuan Province, China. 470589248@qq.com
Key Words Advanced non-small cell lung cancer; Maintenance therapy; S-1; Gemcitabine; Efficacy; Toxic and side effects
Core Tip A comparative study was conducted to observe the efficacy and safety of S-1 maintenance therapy in advanced non-small-cell lung cancer patients. S-1 maintenance therapy has a significant therapeutic effect on patients with advanced non-small-cell lung cancer. It has the same clinical efficacy as gemcitabine, but less toxic and side effects, and is more effective and safer.
Publish Date 2020-11-06 09:07
Citation Cheng XW, Leng WH, Mu CL. Efficacy and safety of S-1 maintenance therapy in advanced non-small-cell lung cancer patients. World J Clin Cases 2020; 8(21): 5172-5179
URL https://www.wjgnet.com/2307-8960/full/v8/i21/5172.htm
DOI https://dx.doi.org/10.12998/wjcc.v8.i21.5172
Full Article (PDF) WJCC-8-5172.pdf
Full Article (Word) WJCC-8-5172.docx